Brief: Onxeo SA Q3 revenues up at 1.23 mln euros
Oct 25 (Reuters) - Onxeo Sa C4X.PA
* Revenues for Q3 of 2016 amounted to 1.23 million euros
($1.34 million) compared to 1.1 million euros in Q3 of 2015
* 12.5 million euros capital increase successfully completed
Source text for Eikon: ID:nBwbB8BG8a
Further company coverage: C4X.PA
($1 = 0.9189 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln